• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Intercept Pharmaceuticals Inc

+ Add to Watchlist

ICPT:US

269.790 USD 1.380 0.51%

As of 20:10:00 ET on 09/16/2014.

Company Profile for Intercept Pharmaceuticals Inc (ICPT)

Intercept Pharmaceuticals, Inc. manufactures and markets biopharmaceutical products. The Company focuses on the development and commercialization of therapeutics to treat chronic liver diseases utilizing proprietary bile acid chemistry. Intercept Pharmaceuticals serves customers throughout the United States.

Contact Information

Intercept Pharmaceuticals Inc

450 West 15th Street
Suite 505
New York, NY 10011
United States
Phone: 1-646-747-1000
Fax: 1-646-747-1001

Key Executives for Intercept Pharmaceuticals Inc (ICPT)

Mark PruzanskiPresident/CEO/Co-FounderBarbara DuncanCFO/Treasurer/Secretary
Daniel P ReganChief Commercial OfficerRachel L McMinnChief Strategy Officer
Luciano AdoriniChief Scientific OfficerDavid ShapiroExec VP:Dev/Chief Medical Ofcr

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil